ClinicalTrials.gg
Not yet recruitingNCT07563569ERCPUpdated May 4, 2026

Determinants of Technical Success and Safety in Therapeutic ERCP for Obstructive Jaundice

An interventional study of ERCP in Obstructive Jaundice, ERCP and Anesthesia Complication, sponsored by Sohag University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-04.

Sponsored by Sohag University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

compare the impact of type of anesthesia on ERCP including technical success, rate of complications, peri procedural safety, patient and endoscopist satisfaction in adult patients with obstructive jaundice

02

Conditions studied

  • Obstructive Jaundice
  • ERCP
  • Anesthesia Complication
  • Anesthesia Effectiveness

Browse trials for

Keywords

  • ERCP
03

In context

Jaundice, Obstructive

62 studies on the registry are indexed under Jaundice, Obstructive; 15 are open to participants now.

This study's planned enrollment of 100 is above the median of 75 across 40 interventional studies indexed under Jaundice, Obstructive.

Browse Jaundice, Obstructive studies →

Lead sponsor

Sohag University is the lead sponsor of 1,230 studies on the registry; 636 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients above 18 years old.
  • Patient with obstructive jaundice as an indication for therapeutic ERCP.
  • Provided written .

Exclusion criteria

Exclusion Criteria:

  • Patients below 18 years old.
  • Indications for ERCP other than obstructive jaundice.
  • with coagulopathy not corrected prior to procedure.
  • severe active cardiopulmonary comorbidities.
  • Previous altered upper GIT anatomy (e.g gastric by-pass).
  • Pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Group A

    50 patient will under go procedure (ERCP) under general anesthesia (25 calcular obstructive jaundice ,25 malignant obstructive jaundice)

    Procedure: ERCP

  • Experimental
    Group B

    50 patient will under go procedure (ERCP)under sedation (25 calcular obstructive jaundice, 25 malignant obstructive jaundice)

    Procedure: ERCP

Interventions

  • ProcedureERCP

    Effect of anesthesia on Therapeutic ERCP in patients obstructive jaundice

06

What researchers measure

Primary outcomes

  1. Impact of type of anesthesia on technical success rate

    Technical success rate defined as successful deep biliary cannulation and completion of the intended therapeutic intervention.

    Time frame: at the time of the procedure

Secondary outcomes

  1. rate of procedure related complications

    Procedure related complication exclusively (post ERCP pancreatitis (based on revised Atlanta criteria), bleeding, perforation, cholangitis and aspiration pneumonia)

    Time frame: at the time of procedure up to 72 hours post procedure

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07563569
Lead sponsor
Sohag University
Responsible party
Mohamed Khaled Abdelazim (Resident doctor, Tropical Medicine and Gastroentrology, Sohag University) — Principal investigator
First posted
May 4, 2026
Start date
May 20, 2026 (estimated)
Primary completion
Nov 20, 2026 (estimated)
Completion
May 20, 2027 (estimated)
Last update
May 4, 2026

Study contacts

Mohamed Khaled Abd El-Azeem
Contact
Mohamed.Eed@med.sohag.edu.eg
01066965222
Mohamed Khaled Abd El-Azeem
principal investigator · Tropical medicine and Gastroentrology department

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion